U.S., Aug. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07131566) titled 'Immune Response in Cervical Lymph Nodes of Patients With Head and Neck Cancer' on June 25.

Brief Summary: Objective:

The aim of this study is to characterize the inflammatory response in patients with head and neck cancer. More specifically, the study intend to investigate inflammatory and genetic differences between the primary tumor, the sentinel lymph node, and other regional lymph nodes. The investigator also aim to assess how the immunological and genetic responses differ in lymph nodes with and without metastases.

To enable the detection of metastases in lymph nodes containing very few cancer cells, the investigator are deve...